STOCK TITAN
  1. Home
  2. Sec-filings
  3. MEDP
  4. [Form 4] Medpace Holdings, Inc. Insider Trading Activity

Medpace (NASDAQ: MEDP) CEO awarded 10,000 RSUs and 20,000 stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Troendle August J. reported acquisition or exercise transactions in this Form 4 filing.

Medpace Holdings, Inc. CEO August J. Troendle reported new equity awards and updated his holdings. He received 10,000 restricted stock units and 20,000 employee stock options, each tied to Medpace common stock. Both awards vest in full on the second anniversary of the grant date, subject to his continued employment.

Following these updates, Troendle holds 646,184 common shares directly and 4,733,019 common shares indirectly through Medpace Investors, LLC, where he has sole voting and investment control but disclaims beneficial ownership beyond his pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Troendle August J.
Role CEO
Type Security Shares Price Value
Grant/Award Employee Stock Option (Right to Buy) 20,000 $0.00 --
Grant/Award Restricted Stock Unit 10,000 $0.00 --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Employee Stock Option (Right to Buy) — 20,000 shares (Direct, null); Restricted Stock Unit — 10,000 shares (Direct, null); Common Stock — 646,184 shares (Direct, null); Common Stock — 4,733,019 shares (Indirect, By Medpace Investors, LLC)
Footnotes (1)
  1. The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. The option vests on the second anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. The restricted stock units vest in full on the second anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
Restricted stock units granted 10,000 units Grant to CEO on April 24, 2026
Stock options granted 20,000 options Employee stock options granted April 24, 2026
Option exercise price $410.5400 per share Conversion or exercise price for 20,000 options
Option expiration April 24, 2033 Expiration date for 20,000 employee stock options
Indirect common shares 4,733,019 shares Held via Medpace Investors, LLC after transactions
Direct common shares 646,184 shares Directly held by CEO after transactions
RSU underlying shares 10,000 shares Common shares underlying restricted stock units
Option underlying shares 20,000 shares Common shares underlying employee stock options
Restricted Stock Unit financial
"security_title": "Restricted Stock Unit""
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Employee Stock Option (Right to Buy) financial
"security_title": "Employee Stock Option (Right to Buy)""
pecuniary interest financial
"disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein"
beneficially own financial
"may be deemed to indirectly beneficially own the securities of the Issuer held by MPI"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
vesting financial
"The option vests on the second anniversary of the grant date"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Troendle August J.
(Last)(First)(Middle)
C/O MEDPACE HOLDINGS, INC.
5375 MEDPACE WAY
(Street)
CINCINNATI OHIO 45227
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/24/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock646,184D
Common Stock4,733,019IBy Medpace Investors, LLC(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy)$410.5404/24/2026A20,000 (2)04/24/2033Common Stock20,000$020,000D
Restricted Stock Unit(3)04/24/2026A10,000 (4) (4)Common Stock10,000$010,000D
Explanation of Responses:
1. The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
2. The option vests on the second anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
3. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
4. The restricted stock units vest in full on the second anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
Remarks:
/s/ Stephen P. Ewald, Attorney-in-Fact for August J. Troendle04/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did MEDP CEO August J. Troendle report on this Form 4?

August J. Troendle reported equity awards rather than open-market trades. He received 10,000 restricted stock units and 20,000 employee stock options, both linked to Medpace common stock, along with updated disclosures of his direct and indirect common share holdings.

How many Medpace (MEDP) shares does August J. Troendle hold after these transactions?

After the reported transactions, August J. Troendle holds 646,184 Medpace common shares directly and 4,733,019 common shares indirectly through Medpace Investors, LLC, where he exercises sole voting and investment control subject to his disclosed pecuniary interest limitations.

What are the details of the new stock option grant to MEDP CEO August J. Troendle?

Troendle received 20,000 employee stock options, each exercisable for one Medpace common share at a conversion or exercise price of $410.5400 per share. The options vest on the second anniversary of the grant date and expire on April 24, 2033.

What are the terms of the restricted stock units granted to Medpace (MEDP) CEO?

The Form 4 shows a grant of 10,000 restricted stock units to Troendle. Each unit represents a contingent right to receive one Medpace common share and vests in full on the second anniversary of the grant date, conditioned on his continued employment.

How are August J. Troendle’s indirect Medpace (MEDP) holdings structured?

His indirect holdings consist of 4,733,019 Medpace common shares held by Medpace Investors, LLC. Troendle is the sole manager and controlling unit holder, with sole voting and investment control, while disclaiming beneficial ownership except to the extent of his pecuniary interest.